TGT vs TPST · P/E 17, rev $51.98B vs $26.3M cap
Target Corporation (TGT) versus Tempest Therapeutics Inc (TPST) — a side-by-side from cached financials, not a winner call.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Brian Cornell.
Tempest Therapeutics Inc (TPST) is a biotechnology company listed on US.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
TPST does not have a complete income-statement cache yet.
TGT currently screens at market cap $58.05B and trailing P/E 16.9. TPST currently screens at market cap $26.3M.
Not investment advice. Open the TGT and TPST stock pages for the full models.
Not investment advice.